THE MCMANUS GROUP for ALLERGAN INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 440, the PACED Act. Support for H.R. 990/S. 344, the Hatch-Waxman Integrity Act.
Foreign entity interest: 100% ownership by Allergan plc, Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Medicare/Medicaid MMM
Medicare Part B drugs payments and access. S. 551, the REFUND Act, H.R. 3, the Lower Drug Costs Now Act of 2019, and H.R. 19, the Lower Costs, More Cures Act of 2019.
Foreign entity interest: 100% ownership by Allergan plc, Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.